Novel electrogravimetric biosensors for the ultrasensitive detection of plasma matrix metalloproteinase-2 considered a potential tumor biomarker

In this study, we developed novel, simple gravimetric and voltammetric sensors for the ultrasensitive detection of active matrix metalloproteinase (MMP)-2 in plasma. The developed sensors are cost-effective, require a very less amount of reagents, and are time-saving. They detect MMP-2 based on anti...

Full description

Saved in:
Bibliographic Details
Published in:Analytica chimica acta 2022-01, Vol.1191, p.339290-339290, Article 339290
Main Authors: Nisiewicz, Monika K., Gajda, Aleksandra, Kowalczyk, Agata, Cupriak, Aleksandra, Kasprzak, Artur, Bamburowicz-Klimkowska, Magdalena, Grudzinski, Ireneusz P., Nowicka, Anna M.
Format: Article
Language:English
Subjects:
Active form
Biomarkers, Tumor
Biosensing Techniques
Cleavage of peptide bond
Electrochemical Techniques
Electrogravimetry
Immunoassay
Immunosensor
Limit of Detection
Matrix Metalloproteinase 2
Metalloproteinase-2
Plasma
Protease
Quartz Crystal Microbalance Techniques
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In this study, we developed novel, simple gravimetric and voltammetric sensors for the ultrasensitive detection of active matrix metalloproteinase (MMP)-2 in plasma. The developed sensors are cost-effective, require a very less amount of reagents, and are time-saving. They detect MMP-2 based on antigen–antibody recognition and its ability to cleave glycine-leucine peptide bond. The three-dimensional bioplatform of the sensors consisted of a cationic polyethyleneimine (PEI) polymer that facilitated robust immobilization of the dipeptide labeled with anthraquinone (AQ), or antibody molecules in appropriate density, which was crucial for biosensing. Detection was performed using quartz crystal microbalance with dissipation and voltammetry. The results showed that the developed sensors were characterized by high stability, wide analytical range (2.0 pg mL−1 to 5.0 μg mL−1), and low detection limit (ca. 10 fg mL−1). They also exhibited excellent efficiency in the determination of active MMP-2 in real samples, such as blood plasma. The developed sensors may hold great promise for the early diagnosis of cancers. [Display omitted] •Gly-Leu-anthraquinone as an excellent voltammetric visualisator.•New protocol for electrogravimetric detection of MMP-2.•Limit of detection at the level of fg·mL−1.•Determination of MMP-2 in plasma.
ISSN:0003-2670
1873-4324
DOI:10.1016/j.aca.2021.339290